✦ LIBER ✦

O-106 A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC)

✍ Scribed by Hanna, N.; Bonomi, P.; Lynch, T.; Ansari, R.; Govindan, R.; Janne, P.; Lilenbaum, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of gemcitabine as second

✍ Gillenwater, HH; Tynan, M; Socinski, MA 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Hyperfractionated irradiation for non-sm

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Phase II trial of VP16-213 in non-small

✍ Robert Chapman; Loretta Itri; Richard Gralla; David Kelsen; Ephraim Casper; Robe 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 238 KB

A multicenter phase II trial with gemcit

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB

An analyis of 134 phase II trials in non

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Phase II trial of oral Idarubicin in adv

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 153 KB